New and Emerging Trends in Cancer Treatment: CAR-T

December 19, 2019

Nearly 40% of men and women will be diagnosed with cancer at some point in their lives. Treatment innovation in this area is critical to fighting the disease.

In an effort to understand these emerging trends, we asked prescribers to share their thoughts on chimeric antigen receptor T cell therapy, also known as CAR T-cell. In this on-demand webinar, prescribers will provide their perceptions on awareness, knowledge and promise. We review the latest CAR T-cell research finding and examine prescriber sentiments towards autologous and allogeneic CAR-T.

Participants will learn more about:

  • Historical context for CAR T-cell as a therapeutic approach
  • Prescriber perspectives on CAR T-cell awareness, treatment and expectations
  • U.S. hematologists’ and oncologists’ analysis of autologous vs. allogeneic CAR-T

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.